Showing results (1901-1910 of 2,044) with videos related to

Sort By:
Pageof 205
Brain Pathology (Zurich, Switzerland)|October 22, 2022
Brain-specific loss of Abcg1 disturbs cholesterol metabolism and aggravates pyroptosis and neurological deficits after traumatic brain injuryHeng Xu, Le-Xin Zheng, Xue-Shi Chen, et al.
Journal of the National Cancer Institute|October 7, 2004
Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorderSameek Roychowdhury, Robert A Baiocchi, Srinivas Vourganti, et al.
Cell|November 6, 2008
Nf1-dependent tumors require a microenvironment containing Nf1+/-- and c-kit-dependent bone marrowFeng-Chun Yang, David A Ingram, Shi Chen, et al.
Molecular Cancer|September 30, 2024
Sulindac (K-80003) with nab-paclitaxel and gemcitabine overcomes drug-resistant pancreatic cancerCheng-Ke Xie, Cheng-Yu Liao, Hong-Yi Lin, et al.
Cell Death & Disease|October 11, 2024
cNEK6 induces gemcitabine resistance by promoting glycolysis in pancreatic ductal adenocarcinoma via the SNRPA/PPA2c/mTORC1 axisGe Li, Fei-Fei She, Cheng-Yu Liao, et al.
Chang Gung Medical Journal|November 1, 2011
Biochemotherapy with carmustine, cisplatin, dacarbazine, tamoxifen and low-dose interleukin-2 for patients with metastatic malignant melanomaPo-Jung Su, Jen-Shi Chen, Chuang-Chi Liaw, et al.
Open Forum Infectious Diseases|February 23, 2023
Clinical Features, Treatment, and Outcome of Psittacosis Pneumonia: A Multicenter StudyYueyan Ni, Huanhuan Zhong, Yu Gu, et al.
Cellular & Molecular Immunology|April 13, 2026
MAIT cell plasticity generates CD4+ MAIT cells that promote HCC progression via metabolic crosstalk with tumor cellsSicheng Fu, Maoyu Tang, Changfeng Zhao, et al.
Digestive Diseases and Sciences|April 2, 2024
Pedigree Analysis of Nonclassical Cholesteryl Ester Storage Disease with Dominant Inheritance in a LIPA I378T Heterozygous CarrierJian-Hui Zhang, Ai-Ping Lin, Li Zhang, et al.
Biomedical Journal|November 15, 2013
Cisplatin, tegafur-uracil and leucovorin plus mitomycin C: an acceptably effective and toxic regimen for patients with recurrent or metastatic nasopharyngeal carcinomaChia-Hsun Hsieh, Cheng-Lung Hsu, Cheng-Hsu Wang, et al.
Pageof 205